VC investment down big, not so much for medtech

Signs that VC investment are at a six-year low came out of a recent Dow Jones VentureSource report

However, as one would expect, medical technology has fared better than the average for aggregate VC investment, with medtech drawing investment in recent months in excess of $400 million per month (see medtech financings by month, 2009). 

There remains higher than average VC funds waiting to be invested, but VC fundraising has slowed, making those uninvested, "idle" funds that much more precious. Q4 will be an important marker of whether an event like the Dow Jones index hitting 10K is a bellwether of optimism to come, or if VC investment is too remotely related.

Posted via email from medmarket’s posterous

Leave a Reply